Quaker Chemical Corp (KWR) · Oct 29, 2026 · Earnings
Beat — Non-GAAP EPS $2.39 vs ~$2.10 consensus; revenue $544.5M vs ~$522.9M
Quaker Houghton’s Q3 earnings beat consensus on strong pricing and new business wins, but input costs pressured margins and cash flow weakened.
Quaker Houghton is a global industrial-process-fluids supplier tied to steel, automotive, aerospace, metalworking and other heavy-manufacturing demand, while using pricing, new business wins and transformation efforts to grow through a soft industrial cycle.
The quarter cleared the market’s bar by a meaningful margin. Non-GAAP EPS was $2.39 versus published consensus of roughly $2.10, while revenue reached $544.5 million versus roughly $522.9 million expected. That is a genuine earnings beat, not just a recovery against last year’s weak comparison. (Financial Highlights)
| Metric | Q3 2026 | Q3 2025 | Consensus |
|---|---|---|---|
| Net sales (Financial Highlights) | $544.5M (+10.3%) | $493.8M | ~$522.9M |
| Non-GAAP EPS (Financial Highlights) | $2.39 (+14.9%) | $2.08 | ~$2.10 |
| Adjusted EBITDA (Financial Highlights) | $89.8M (+8.4%) | $82.9M | |
| Adjusted EBITDA margin (Financial Highlights) | 16.5% (-0.3 pts) | 16.8% | |
| Operating cash flow, YTD (Cash Flow statement) | $47.6M (-47.1%) | $89.9M |
The quality of growth is better than the headline demand environment. Revenue rose 10%, but the filing says underlying end-market activity was flat to slightly lower; the volume increase came from new business wins, while pricing and mix contributed 7% of growth. That means execution and customer wins are carrying the story more than a broad industrial recovery. (Segment results) 〔0〕
Profitability improved in dollars but not in margin. Adjusted EBITDA rose 8%, yet adjusted EBITDA margin fell to 16.5% from 16.8%, and non-GAAP operating margin edged down to 11.6% from 11.7%. Higher input costs and SG&A absorbed part of the benefit from pricing and growth, with Asia/Pacific particularly pressured by persistent input-cost inflation. (Financial Highlights; Segment results)
The outlook supports continued year-over-year progress, not a clean acceleration. Management expects fourth-quarter revenue and adjusted EBITDA to improve from the prior year but decline sequentially from Q3’s record level because of seasonal demand, softer Chinese industrial activity and elevated raw-material costs. That is broadly consistent with a company still executing well in a difficult backdrop, rather than raising the bar with a new quantitative outlook. (Management commentary) 〔1〕
Cash conversion is the main blemish. Year-to-date operating cash flow fell to $47.6 million from $89.9 million, largely because receivables, inventories and other working-capital accounts consumed cash. Leverage remained manageable at about 2.3x net debt to trailing adjusted EBITDA, so this is more an execution and working-capital issue than an immediate balance-sheet stress signal. (Cash Flow statement; Liquidity update)
Bottom line: This was a real earnings and revenue beat, powered by pricing and new customer wins despite weak underlying markets. The result advances the recovery story, but softer margins and weaker cash generation keep it from being a clean, broad-based upside quarter.
Q3 earnings call, October 30
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!